MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/alz.70502

Медицинская библиотека · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

Early microglial and astrocyte reactivity in preclinical Alzheimer's disease.

Fernández-Matarrubia Marta, Valera-Barrero Andrea, Renuncio-García Mónica, Aguilella Marcos, Lage Carmen, López-García Sara, Ocejo-Vinyals J Gonzalo, Martínez-Dubarbie Francisco, Molfetta Guglielmo Di, Pozueta-Cantudo Ana, García-Martínez María, Corrales-Pardo Andrea, Bravo María, López-Hoyos Marcos, Irure-Ventura Juan, Blennow Kaj, Ashton Nicholas J, Zetterberg Henrik, Sánchez-Juan Pascual, Rodríguez-Rodríguez Eloy

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

The role of neuroinflammation in preclinical Alzheimer's disease (AD) remains unclear.

METHODS

We assessed changes in microglial and astrocytic biomarkers in a well-characterized cohort of 211 cognitively unimpaired individuals. Structural equation modeling was used to simultaneously assess all relationships among microglial and astrocytic responses and AD pathological events.

RESULTS

Plasma glial fibrillary acidic protein (GFAP) and cerebrospinal fluid (CSF) soluble triggering receptor expressed on myeloid cells 2 (sTREM2) were increased in preclinical AD. Plasma GFAP showed an inverse bidirectional relationship with CSF amyloid beta (Aβ)42/40. CSF sTREM2 directly influenced CSF phosphorylated tau-181 (p-tau181) and neurogranin, and correlated with CSF S100 calcium-binding protein beta (S100β). CSF chitinase-3-like protein 1 (YKL-40) mediated the association between CSF p-tau181 and total tau (t-tau), whereas CSF S100β and neurofilament light showed mutual influence.

DISCUSSION: Our findings suggest that microglial and astrocyte reactivity, measured through fluid biomarkers, occur early and impact the amyloid cascade on the preclinical Alzheimer´s continuum. Specifically, GFAP influences amyloid accumulation, sTREM2 promotes tau pathology, and YKL-40 and S100β contribute to the progression of downstream neurodegenerative changes.

HIGHLIGHTS: Preclinical Alzheimer's disease (AD) showed increased levels of plasma glial fibrillary acidic protein (GFAP) and soluble triggering receptor expressed on myeloid cells 2 (sTREM2) compared to cerebrospinal fluid (CSF) in healthy subjects. Higher plasma GFAP levels was directly associated with lower CSF amyloid beta (Aβ)42/Aβ40. Higher CSF sTREM2 concentrations increased CSF phosphorylated tau-181. Chitinase-3-like protein 1 (YKL-40) mediated tau-induced neurodegeneration. S100 calcium-binding protein beta (S100β) was directly linked to higher neurofilament light (NfL) and showed a mutual relationship with sTREM2.

Для цитирования: Fernández-Matarrubia Marta, Valera-Barrero Andrea, Renuncio-García Mónica, Aguilella Marcos, Lage Carmen, López-García Sara, Ocejo-Vinyals J Gonzalo, Martínez-Dubarbie Francisco, Molfetta Guglielmo Di, Pozueta-Cantudo Ana, García-Martínez María, Corrales-Pardo Andrea, Bravo María, López-Hoyos Marcos, Irure-Ventura Juan, Blennow Kaj, Ashton Nicholas J, Zetterberg Henrik, Sánchez-Juan Pascual, Rodríguez-Rodríguez Eloy. Early microglial and astrocyte reactivity in preclinical Alzheimer's disease.. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2025. DOI: 10.1002/alz.70502.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.